Fish oil helps statins protect blood vessels.

Original title: Fish oil can assist statin vascular care
Recently, the U.S. Food and Drug Administration (FDA) approved a fish oil derivative as an ancillary therapy for statins for adult patients with elevated levels of triglycerides (TGs), cardiovascular disease or diabetes, multiple cardiovascular risk factors, reducing the risk of myocardial infarction, stroke, coronary artery resuscemia, and unstable angina.
main component of this fish oil derivative is 20 carbon ethyl acetate. A clinically controlled study grouped 8,179 patients treated with statins, which reduced the relative risk of first adverse cardiovascular events by 25 percent and overall (including first and subsequent) cardiovascular events by 30 percent compared to the placebo group.
disease remains the number one killer of humans worldwide. Although statins can reduce the risk of cardiovascular adverse events, many patients have high levels of triglycerides (TG), an important indicator of cardiovascular disease, when LDL cholesterol levels drop to a standard level, which can have serious health consequences if statin use is increased. "FDA approval of the drug as a supplement to statin therapy to reduce the risk of cardiovascular events is an important milestone in the prevention of cardiovascular disease, and many patients will benefit from it," said Shankar Butt, a professor of medicine at Harvard Medical School and an expert in cardiovascular interventional therapy. "
.